20 results on '"Larsson, Jimmy"'
Search Results
2. Real-time measurements of aminoglycoside effects on protein synthesis in live cells
- Author
-
Rivera, Javier Aguirre, Larsson, Jimmy, Volkov, Ivan L., Seefeldt, A. Carolin, Sanyal, Suparna, and Johansson, Magnus
- Published
- 2021
3. RecA finds homologous DNA by reduced dimensionality search
- Author
-
Wiktor, Jakub, Gynnå, Arvid H., Leroy, Prune, Larsson, Jimmy, Coceano, Giovanna, Testa, Ilaria, and Elf, Johan
- Subjects
RecA proteins -- Structure -- Physiological aspects ,DNA repair -- Models ,Genetic recombination -- Models ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Homologous recombination is essential for the accurate repair of double-stranded DNA breaks (DSBs).sup.1. Initially, the RecBCD complex.sup.2 resects the ends of the DSB into 3' single-stranded DNA on which a RecA filament assembles.sup.3. Next, the filament locates the homologous repair template on the sister chromosome.sup.4. Here we directly visualize the repair of DSBs in single cells, using high-throughput microfluidics and fluorescence microscopy. We find that, in Escherichia coli, repair of DSBs between segregated sister loci is completed in 15 [plus or minus] 5 min (mean [plus or minus] s.d.) with minimal fitness loss. We further show that the search takes less than 9 [plus or minus] 3 min (mean [plus or minus] s.d) and is mediated by a thin, highly dynamic RecA filament that stretches throughout the cell. We propose that the architecture of the RecA filament effectively reduces search dimensionality. This model predicts a search time that is consistent with our measurement and is corroborated by the observation that the search time does not depend on the length of the cell or the amount of DNA. Given the abundance of RecA homologues.sup.5, we believe this model to be widely conserved across living organisms. Observations of rapid repair of double-stranded DNA breaks in sister choromosomes in Escherichia coli are consistent with a reduced-dimensionality-search model of RecA-mediated repair., Author(s): Jakub Wiktor [sup.1] , Arvid H. Gynnå [sup.1] , Prune Leroy [sup.1] , Jimmy Larsson [sup.1] , Giovanna Coceano [sup.2] , Ilaria Testa [sup.2] , Johan Elf [sup.1] Author [...]
- Published
- 2021
- Full Text
- View/download PDF
4. The highly dynamic nature of bacterial heteroresistance impairs its clinical detection
- Author
-
Pereira, Cátia, Larsson, Jimmy, Hjort, Karin, Elf, Johan, and Andersson, Dan I.
- Published
- 2021
- Full Text
- View/download PDF
5. Time-resolved imaging-based CRISPRi screening
- Author
-
Camsund, Daniel, Lawson, Michael J., Larsson, Jimmy, Jones, Daniel, Zikrin, Spartak, Fange, David, and Elf, Johan
- Published
- 2020
- Full Text
- View/download PDF
6. Author Correction: RecA finds homologous DNA by reduced dimensionality search
- Author
-
Wiktor, Jakub, Gynnå, Arvid H., Leroy, Prune, Larsson, Jimmy, Coceano, Giovanna, Testa, Ilaria, and Elf, Johan
- Published
- 2021
- Full Text
- View/download PDF
7. Antibiotic perseverance increases the risk of resistance development.
- Author
-
Brandis, Gerrit, Larsson, Jimmy, and Elf, Johan
- Subjects
- *
ANTIBIOTICS , *DRUG resistance in bacteria , *PATHOGENIC bacteria , *BACTERIAL diseases , *GRAM-negative bacteria - Abstract
The rise of antibiotic-resistant bacterial infections poses a global threat. Antibiotic resistance development is generally studied in batch cultures which conceals the heterogeneity in cellular responses. Using single-cell imaging, we studied the growth response of Escherichia coli to sub-inhibitory and inhibitory concentrations of nine antibiotics. We found that the heterogeneity in growth increases more than what is expected from growth rate reduction for three out of the nine antibiotics tested. For two antibiotics (rifampicin and nitrofurantoin), we found that sub-populations were able to maintain growth at lethal antibiotic concentrations for up to 10 generations. This perseverance of growth increased the population size and led to an up to 40-fold increase in the frequency of antibiotic resistance mutations in gram-negative and gram-positive species. We conclude that antibiotic perseverance is a common phenomenon that has the potential to impact antibiotic resistance development across pathogenic bacteria. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Functional genomics of monensin sensitivity in yeast: implications for post-Golgi traffic and vacuolar H+-ATPase function
- Author
-
Gustavsson, Marie, Barmark, Gunilla, Larsson, Jimmy, Murén, Eva, and Ronne, Hans
- Published
- 2008
- Full Text
- View/download PDF
9. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells
- Author
-
Erlandsson, Anna, Larsson, Jimmy, and Forsberg-Nilsson, Karin
- Published
- 2004
- Full Text
- View/download PDF
10. Real-time measurements of aminoglycoside effects on protein synthesis in live cells.
- Author
-
Aguirre Rivera, Javier, Larsson, Jimmy, Volkov, Ivan L., Seefeldt, A. Carolin, Sanyal, Suparna, and Johansson, Magnus
- Subjects
- *
PROTEIN synthesis , *TRANSFER RNA , *DRUG utilization , *MESSENGER RNA , *DRUG resistance in bacteria , *COMMERCIAL products - Abstract
The spread of antibiotic resistance is turning many of the currently used antibiotics less effective against common infections. To address this public health challenge, it is critical to enhance our understanding of the mechanisms of action of these compounds. Aminoglycoside drugs bind the bacterial ribosome, and decades of results from in vitro biochemical and structural approaches suggest that these drugs disrupt protein synthesis by inhibiting the ribosome's translocation on the messenger RNA, as well as by inducing miscoding errors. So far, however, we have sparse information about the dynamic effects of these compounds on protein synthesis inside the cell. In the present study, we measured the effect of the aminoglycosides apramycin, gentamicin, and paromomycin on ongoing protein synthesis directly in live Escherichia coli cells by tracking the binding of dye-labeled transfer RNAs to ribosomes. Our results suggest that the drugs slow down translation elongation two- to fourfold in general, and the number of elongation cycles per initiation event seems to decrease to the same extent. Hence, our results imply that none of the drugs used in this study cause severe inhibition of translocation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Paladin is a phosphoinositide phosphatase regulating endosomal VEGFR2 signalling and angiogenesis.
- Author
-
Nitzsche, Anja, Pietilä, Riikka, Love, Dominic T, Testini, Chiara, Ninchoji, Takeshi, Smith, Ross O, Ekvärn, Elisabet, Larsson, Jimmy, Roche, Francis P, Egaña, Isabel, Jauhiainen, Suvi, Berger, Philipp, Claesson‐Welsh, Lena, and Hellström, Mats
- Abstract
Cell signalling governs cellular behaviour and is therefore subject to tight spatiotemporal regulation. Signalling output is modulated by specialized cell membranes and vesicles which contain unique combinations of lipids and proteins. The phosphatidylinositol 4,5‐bisphosphate (PI(4,5)P2), an important component of the plasma membrane as well as other subcellular membranes, is involved in multiple processes, including signalling. However, which enzymes control the turnover of non‐plasma membrane PI(4,5)P2, and their impact on cell signalling and function at the organismal level are unknown. Here, we identify Paladin as a vascular PI(4,5)P2 phosphatase regulating VEGFR2 endosomal signalling and angiogenesis. Paladin is localized to endosomal and Golgi compartments and interacts with vascular endothelial growth factor receptor 2 (VEGFR2) in vitro and in vivo. Loss of Paladin results in increased internalization of VEGFR2, over‐activation of extracellular regulated kinase 1/2, and hypersprouting of endothelial cells in the developing retina of mice. These findings suggest that inhibition of Paladin, or other endosomal PI(4,5)P2 phosphatases, could be exploited to modulate VEGFR2 signalling and angiogenesis, when direct and full inhibition of the receptor is undesirable. SYNOPSIS: This study identifies Paladin as a vascular PI(4,5)P2 phosphatase, which restricts VEGFR2 internalization and activation of downstream signaling, thereby dampening angiogenesis. Paladin is a phosphoinositide phosphatase with preference for PI(4,5)P2.VEGF‐A induces co‐localization of Paladin with VEGFR2 in EEA1+ early endosomes.Paladin deficiency promotes increased VEGFR2 phosphorylation, internalization, and ERK1/2 signalling.Increased ERK1/2 signalling in Paladin knockout mice leads to endothelial cell hypersprouting in physiological and pathological retinal angiogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.
- Author
-
Kundu, Snehangshu, Ali, Muhammad Akhtar, Handin, Niklas, Padhan, Narendra, Larsson, Jimmy, Karoutsou, Maria, Ban, Kenneth, Wiśniewski, Jacek R., Artursson, Per, He, Liqun, Hellström, Mats, and Sjöblom, Tobias
- Subjects
GENETICS of colon cancer ,RAS oncogenes ,FORKHEAD transcription factors ,MITOGEN-activated protein kinases ,PHOSPHORYLATION ,GENETIC mutation - Abstract
Background: The Ras pathway genes KRAS, BRAF, or ERBBs have somatic mutations in ~ 60% of human colorectal carcinomas. At present, it is unknown whether the remaining cases lack mutations activating the Ras pathway or whether they have acquired mutations in genes hitherto unknown to belong to the pathway. Methods: To address the second possibility and extend the compendium of Ras pathway genes, we used genomewide transposon mutagenesis of two human colorectal cancer cell systems deprived of their activating KRAS or BRAF allele to identify genes enabling growth in low glucose, a Ras pathway phenotype, when targeted. Results: Of the 163 recurrently targeted genes in the two different genetic backgrounds, one-third were known cancer genes and one-fifth had links to the EGFR/Ras/MAPK pathway. When compared to cancer genome sequencing datasets, nine genes also mutated in human colorectal cancers were identified. Among these, stable knockdown of FOXO3, NCOA3, and TCF7L2 restored growth in low glucose but reduced MEK/MAPK phosphorylation, reduced anchorage-independent growth, and modulated expressions of GLUT1 and Ras pathway related proteins. Knockdown of NCOA3 and FOXO3 significantly decreased the sensitivity to cetuximab of KRAS mutant but not wild-type cells. Conclusions: This work establishes a proof-of-concept that human cell-based genome-wide forward genetic screens can assign genes to pathways with clinical importance in human colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. In situ genotyping of a pooled strain library after characterizing complex phenotypes.
- Author
-
Lawson, Michael J, Camsund, Daniel, Larsson, Jimmy, Baltekin, Özden, Fange, David, and Elf, Johan
- Subjects
PHENOTYPES ,MICROSCOPY ,FLUORESCENCE ,PLASMIDS ,GENES - Abstract
In this work, we present a proof-of-principle experiment that extends advanced live cell microscopy to the scale of pool-generated strain libraries. We achieve this by identifying the genotypes for individual cells in situ after a detailed characterization of the phenotype. The principle is demonstrated by single-molecule fluorescence time-lapse imaging of Escherichia coli strains harboring barcoded plasmids that express a sgRNA which suppresses different genes in the E. coli genome through dCas9 interference. In general, the method solves the problem of characterizing complex dynamic phenotypes for diverse genetic libraries of cell strains. For example, it allows screens of how changes in regulatory or coding sequences impact the temporal expression, location, or function of a gene product, or how the altered expression of a set of genes impacts the intracellular dynamics of a labeled reporter. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
14. Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development.
- Author
-
Wallgard, Elisabet, Nitzsche, Anja, Larsson, Jimmy, Guo, Xiaoyuan, Dieterich, Lothar C., Dimberg, Anna, Olofsson, Tommie, Pontén, Fredrik C., Mäkinen, Taija, Kalén, Mattias, and Hellström, Mats
- Abstract
Background: Angiogenesis is implicated in many pathological conditions. The role of the proteins involved remains largely unknown, and few vascular-specific drug targets have been discovered. Previously, in a screen for angiogenesis regulators, we identified Paladin (mouse: X99384, human: KIAA1274), a protein containing predicted S/T/Y phosphatase domains. Results: We present a mouse knockout allele for Paladin with a β-galactosidase reporter, which in combination with Paladin antibodies demonstrate that Paladin is expressed in the vasculature. During mouse embryogenesis, Paladin is primarily expressed in capillary and venous endothelial cells. In adult mice Paladin is predominantly expressed in arterial pericytes and vascular smooth muscle cells. Paladin also displays vascular-restricted expression in human brain, astrocytomas, and glioblastomas. Conclusions: Paladin, a novel putative phosphatase, displays a dynamic expression pattern in the vasculature. During embryonic stages it is broadly expressed in endothelial cells, while in the adult it is selectively expressed in arterial smooth muscle cells. Developmental Dynamics 241:770-786, 2012. © 2012 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
15. Inactivation of Pmel Alters Melanosome Shape But Has Only a Subtle Effect on Visible Pigmentation.
- Author
-
Hellström, Anders R., Watt, Brenda, Fard, Shahrzad Shirazi, Tenza, Danièle, Mannström, Paula, Narfströ, Kristina, Ekesten, Björn, Ito, Shosuke, Wakamatsu, Kazumasa, Larsson, Jimmy, Ulfendahl, Mats, Kullander, Klas, Raposo, Graça, Kerje, Susanne, Hallböök, Finn, Marks, Michael S., and Andersson, Leif
- Subjects
BIOLOGICAL pigments ,MELANINS ,MELANOCYTES ,GENETIC mutation ,PHENOTYPES ,EPITHELIUM ,CELL culture ,LABORATORY mice - Abstract
PMEL is an amyloidogenic protein that appears to be exclusively expressed in pigment cells and forms intralumenal fibrils within early stage melanosomes upon which eumelanins deposit in later stages. PMEL is well conserved among vertebrates, and allelic variants in several species are associated with reduced levels of eumelanin in epidermal tissues. However, in most of these cases it is not clear whether the allelic variants reflect gain-of-function or loss-of-function, and no complete PMEL loss-of-function has been reported in a mammal. Here, we have created a mouse line in which the Pmel gene has been inactivated (Pmel
-/- ). These mice are fully viable, fertile, and display no obvious developmental defects. Melanosomes within Pmel-/- melanocytes are spherical in contrast to the oblong shape present in wild-type animals. This feature was documented in primary cultures of skin-derived melanocytes as well as in retinal pigment epithelium cells and in uveal melanocytes. Inactivation of Pmel has only a mild effect on the coat color phenotype in four different genetic backgrounds, with the clearest effect in mice also carrying the brown/Tyrp1 mutation. This phenotype, which is similar to that observed with the spontaneous silver mutation in mice, strongly suggests that other previously described alleles in vertebrates with more striking effects on pigmentation are dominant-negative mutations. Despite a mild effect on visible pigmentation, inactivation of Pmel led to a substantial reduction in eumelanin content in hair, which demonstrates that PMEL has a critical role for maintaining efficient epidermal pigmentation. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
16. The gene expression profile of PDGF-treated neural stem cells corresponds to partially differentiated neurons and glia.
- Author
-
Demoulin, Jean-Baptiste, Enarsson, Mia, Larsson, Jimmy, Essaghir, Ahmed, Heldin, Carl-Henrik, and Forsberg-Nilsson, Karin
- Subjects
GENE expression ,NEURAL stem cells ,NEURONS ,NEUROGLIA ,CELL cycle - Abstract
We have previously shown that platelet-derived growth factor AA (PDGF-AA) stimulates the expansion of neuronal progenitors from neural stem cells, but is unable to replace fibroblast-growth factor 2 (FGF-2) as a stem cell mitogen. In the present study, we compared gene expression in neural stem cells that were grown in the presence of FGF-2 and in cells cultured with PDGF-AA or in the absence of growth factor, which induces differentiation. The genetic program elicited by PDGF-AA (156 significantly regulated genes) was not unique, but an intermediate between the ones of FGF-2-cultured stem cells and differentiated cells. These observations are compatible with the hypothesis that PDGF-AA induces a partial differentiation of neural stem cells, which retain the ability to proliferate, rather than acting solely as an instructing agent for neuronal differentiation. Finally, the transcriptional signature of stem cells grown with FGF-2 included a large number of genes over-expressed in gliomas and a core set of conserved genes periodically expressed during the eukaryote cell cycle. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
17. The Sphingosine-1-Phosphate Receptor S1PR1 Restricts Sprouting Angiogenesis by Regulating the Interplay between VE-Cadherin and VEGFR2
- Author
-
Gaengel, Konstantin, Niaudet, Colin, Hagikura, Kazuhiro, Siemsen, Bàrbara Laviña, Muhl, Lars, Hofmann, Jennifer J., Ebarasi, Lwaki, Nyström, Staffan, Rymo, Simin, Chen, Long Long, Pang, Mei-Fong, Jin, Yi, Raschperger, Elisabeth, Roswall, Pernilla, Schulte, Dörte, Benedito, Rui, Larsson, Jimmy, Hellström, Mats, Fuxe, Jonas, and Uhlén, Per
- Subjects
- *
SPHINGOSINE-1-phosphate , *NEOVASCULARIZATION inhibitors , *CADHERINS , *VASCULAR endothelial growth factors , *BLOOD vessels , *EMBRYOLOGY , *ENDOTHELIAL cells - Abstract
Summary: Angiogenesis, the process by which new blood vessels arise from preexisting ones, is critical for embryonic development and is an integral part of many disease processes. Recent studies have provided detailed information on how angiogenic sprouts initiate, elongate, and branch, but less is known about how these processes cease. Here, we show that S1PR1, a receptor for the blood-borne bioactive lipid sphingosine-1-phosphate (S1P), is critical for inhibition of angiogenesis and acquisition of vascular stability. Loss of S1PR1 leads to increased endothelial cell sprouting and the formation of ectopic vessel branches. Conversely, S1PR1 signaling inhibits angiogenic sprouting and enhances cell-to-cell adhesion. This correlates with inhibition of vascular endothelial growth factor-A (VEGF-A)-induced signaling and stabilization of vascular endothelial (VE)-cadherin localization at endothelial junctions. Our data suggest that S1PR1 signaling acts as a vascular-intrinsic stabilization mechanism, protecting developing blood vessels against aberrant angiogenic responses. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
18. Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth.
- Author
-
Pandzic T, Rendo V, Lim J, Larsson C, Larsson J, Stoimenov I, Kundu S, Ali MA, Hellström M, He L, Lindroth AM, and Sjöblom T
- Abstract
The chromatin modifier PRDM2/RIZ1 is inactivated by mutation in several forms of cancer and is a putative tumor suppressor gene. Frameshift mutations in the C-terminal region of PRDM2 , affecting (A)8 or (A)9 repeats within exon 8, are found in one third of colorectal cancers with microsatellite instability, but the contribution of these mutations to colorectal tumorigenesis is unknown. To model somatic mutations in microsatellite unstable tumors, we devised a general approach to perform genome editing while stabilizing the mutated nucleotide repeat. We then engineered isogenic cell systems where the PRDM2 c.4467delA mutation in human HCT116 colorectal cancer cells was corrected to wild-type by genome editing. Restored PRDM2 increased global histone 3 lysine 9 dimethylation and reduced migration, anchorage-independent growth and tumor growth in vivo . Gene set enrichment analysis revealed regulation of several hallmark cancer pathways, particularly of epithelial-to-mesenchymal transition (EMT), with VIM being the most significantly regulated gene. These observations provide direct evidence that PRDM2 c.4467delA is a driver mutation in colorectal cancer and confirms PRDM2 as a cancer gene, pointing to regulation of EMT as a central aspect of its tumor suppressive action., Competing Interests: CONFLICTS OF INTEREST The authors have no conflicts of interest to disclose.
- Published
- 2017
- Full Text
- View/download PDF
19. Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia.
- Author
-
Pandzic T, Larsson J, He L, Kundu S, Ban K, Akhtar-Ali M, Hellström AR, Schuh A, Clifford R, Blakemore SJ, Strefford JC, Baumann T, Lopez-Guillermo A, Campo E, Ljungström V, Mansouri L, Rosenquist R, Sjöblom T, and Hellström M
- Subjects
- Antineoplastic Agents pharmacology, Humans, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins B-raf metabolism, Transcription Factors metabolism, Tumor Cells, Cultured, Vidarabine pharmacology, DNA Transposable Elements genetics, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm genetics, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Mutagenesis genetics, Vidarabine analogs & derivatives
- Abstract
Purpose: To identify resistance mechanisms for the chemotherapeutic drug fludarabine in chronic lymphocytic leukemia (CLL), as innate and acquired resistance to fludarabine-based chemotherapy represents a major challenge for long-term disease control., Experimental Design: We used piggyBac transposon-mediated mutagenesis, combined with next-generation sequencing, to identify genes that confer resistance to fludarabine in a human CLL cell line., Results: In total, this screen identified 782 genes with transposon integrations in fludarabine-resistant pools of cells. One of the identified genes is a known resistance mediator DCK (deoxycytidine kinase), which encodes an enzyme that is essential for the phosphorylation of the prodrug to the active metabolite. BMP2K, a gene not previously linked to CLL, was also identified as a modulator of response to fludarabine. In addition, 10 of 782 transposon-targeted genes had previously been implicated in treatment resistance based on somatic mutations seen in patients refractory to fludarabine-based therapy. Functional characterization of these genes supported a significant role for ARID5B and BRAF in fludarabine sensitivity. Finally, pathway analysis of transposon-targeted genes and RNA-seq profiling of fludarabine-resistant cells suggested deregulated MAPK signaling as involved in mediating drug resistance in CLL., Conclusions: To our knowledge, this is the first forward genetic screen for chemotherapy resistance in CLL. The screen pinpointed novel genes and pathways involved in fludarabine resistance along with previously known resistance mechanisms. Transposon screens can therefore aid interpretation of cancer genome sequencing data in the identification of genes modifying sensitivity to chemotherapy. Clin Cancer Res; 22(24); 6217-27. ©2016 AACR., (©2016 American Association for Cancer Research.)
- Published
- 2016
- Full Text
- View/download PDF
20. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
- Author
-
Mansouri L, Sutton LA, Ljungström V, Bondza S, Arngården L, Bhoi S, Larsson J, Cortese D, Kalushkova A, Plevova K, Young E, Gunnarsson R, Falk-Sörqvist E, Lönn P, Muggen AF, Yan XJ, Sander B, Enblad G, Smedby KE, Juliusson G, Belessi C, Rung J, Chiorazzi N, Strefford JC, Langerak AW, Pospisilova S, Davi F, Hellström M, Jernberg-Wiklund H, Ghia P, Söderberg O, Stamatopoulos K, Nilsson M, and Rosenquist R
- Subjects
- Cell Nucleus metabolism, Cell Survival, Chromosome Aberrations, Cohort Studies, Cytoplasm metabolism, DNA Mutational Analysis, Frameshift Mutation, Gene Deletion, Gene Expression Profiling, Humans, I-kappa B Kinase genetics, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Lymphoma, B-Cell metabolism, Lymphoma, B-Cell, Marginal Zone metabolism, Lymphoma, Mantle-Cell metabolism, Oligonucleotide Array Sequence Analysis, Receptors, Antigen, B-Cell metabolism, Signal Transduction, Treatment Outcome, Gene Expression Regulation, Leukemic, I-kappa B Kinase physiology, Leukemia, Lymphocytic, Chronic, B-Cell metabolism, NF-kappa B metabolism
- Abstract
NF-κB is constitutively activated in chronic lymphocytic leukemia (CLL); however, the implicated molecular mechanisms remain largely unknown. Thus, we performed targeted deep sequencing of 18 core complex genes within the NF-κB pathway in a discovery and validation CLL cohort totaling 315 cases. The most frequently mutated gene was NFKBIE (21/315 cases; 7%), which encodes IκBε, a negative regulator of NF-κB in normal B cells. Strikingly, 13 of these cases carried an identical 4-bp frameshift deletion, resulting in a truncated protein. Screening of an additional 377 CLL cases revealed that NFKBIE aberrations predominated in poor-prognostic patients and were associated with inferior outcome. Minor subclones and/or clonal evolution were also observed, thus potentially linking this recurrent event to disease progression. Compared with wild-type patients, NFKBIE-deleted cases showed reduced IκBε protein levels and decreased p65 inhibition, along with increased phosphorylation and nuclear translocation of p65. Considering the central role of B cell receptor (BcR) signaling in CLL pathobiology, it is notable that IκBε loss was enriched in aggressive cases with distinctive stereotyped BcR, likely contributing to their poor prognosis, and leading to an altered response to BcR inhibitors. Because NFKBIE deletions were observed in several other B cell lymphomas, our findings suggest a novel common mechanism of NF-κB deregulation during lymphomagenesis., (© 2015 Mansouri et al.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.